Medicine Man Technologies, Inc.
SHWZ
$0.00
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -7.14% | 10.10% | |||
| Total Other Revenue | -98.61% | 5,411.76% | |||
| Total Revenue | -7.32% | 10.32% | |||
| Cost of Revenue | 43.39% | 41.74% | |||
| Gross Profit | -67.19% | -12.57% | |||
| SG&A Expenses | 71.59% | -36.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 52.72% | 1.08% | |||
| Operating Income | -261.82% | 80.00% | |||
| Income Before Tax | -585.82% | 449.44% | |||
| Income Tax Expenses | -17.42% | 5.82% | |||
| Earnings from Continuing Operations | -9,005.33% | 95.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9,005.33% | 95.12% | |||
| EBIT | -261.82% | 80.00% | |||
| EBITDA | -166.74% | 43.28% | |||
| EPS Basic | -1,959.35% | 85.54% | |||
| Normalized Basic EPS | -601.36% | 343.05% | |||
| EPS Diluted | -1,451.76% | 81.07% | |||
| Normalized Diluted EPS | -866.67% | 258.94% | |||
| Average Basic Shares Outstanding | -17.80% | 44.05% | |||
| Average Diluted Shares Outstanding | -46.13% | 119.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||